| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $9.2M | +55.1% |
| SG&A Expense | $4.7M | +4.5% |
| Operating Income | -$13.9M | -33.1% |
| Pre-tax Income | -$13.9M | -32.8% |
| Income Tax | $0 | — |
| Net Income | -$13.9M | -32.8% |
| EPS (Basic) | -$1.91 | -23.2% |
| EPS (Diluted) | -$1.91 | -23.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $15.6M | -40.3% |
| Total Assets | $16.0M | -39.9% |
| Current Liabilities | $1.7M | +75.8% |
| Total Liabilities | $1.8M | +61.7% |
| Stockholders' Equity | $14.2M | -44.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.1M | -52.3% |
| Capital Expenditures | $21K | -70.0% |
| Investing Cash Flow | -$21K | +70.0% |
| Financing Cash Flow | $1.7M | -91.3% |
| Free Cash Flow | -$15.1M | -51.4% |